163 related articles for article (PubMed ID: 8584531)
1. [Monitoring ototoxic side effects in streptomycin therapy of tuberculosis patients with transitory evoked otoacoustic emissions TEOAE].
Fürst G; Maurer J; Schlegel J
Pneumologie; 1995 Nov; 49(11):590-5. PubMed ID: 8584531
[TBL] [Abstract][Full Text] [Related]
2. Factors affecting sensitivity of distortion-product otoacoustic emissions to ototoxic hearing loss.
Reavis KM; Phillips DS; Fausti SA; Gordon JS; Helt WJ; Wilmington D; Bratt GW; Konrad-Martin D
Ear Hear; 2008 Dec; 29(6):875-93. PubMed ID: 18753950
[TBL] [Abstract][Full Text] [Related]
3. Transient-evoked otoacoustic emissions in a group of professional singers who have normal pure-tone hearing thresholds.
Hamdan AL; Abouchacra KS; Zeki Al Hazzouri AG; Zaytoun G
Ear Hear; 2008 Jun; 29(3):360-77. PubMed ID: 18382377
[TBL] [Abstract][Full Text] [Related]
4. [Correlation between auditory threshold and transitory evoked otoacoustic emissions].
Komazec Z; Milosević D; Mocko M; Dankuc D; Vlaski L
Srp Arh Celok Lek; 2002; 130 Suppl 1():8-11. PubMed ID: 12395455
[TBL] [Abstract][Full Text] [Related]
5. [Clinical use of transitory otoacoustic evoked emissions in therapeutic follow-up].
Hoth S; Bönnhoff S
HNO; 1993 Mar; 41(3):135-45. PubMed ID: 7682543
[TBL] [Abstract][Full Text] [Related]
6. Distortion-product otoacoustic emissions and cochlear microphonics: relationships in patients with and without endolymphatic hydrops.
Fetterman BL
Laryngoscope; 2001 Jun; 111(6):946-54. PubMed ID: 11404602
[TBL] [Abstract][Full Text] [Related]
7. Otoacoustic emissions in early noise-induced hearing loss.
Shupak A; Tal D; Sharoni Z; Oren M; Ravid A; Pratt H
Otol Neurotol; 2007 Sep; 28(6):745-52. PubMed ID: 17721363
[TBL] [Abstract][Full Text] [Related]
8. Clinical investigation on spontaneous otoacoustic emission (SOAE) in 447 ears.
Kuroda T
Auris Nasus Larynx; 2007 Mar; 34(1):29-38. PubMed ID: 17116381
[TBL] [Abstract][Full Text] [Related]
9. [Monitoring drug ototoxicity with distortion products].
Orts Alborch M; Morant Ventura A; García Callejo J; Ferrer Baixauli F; Martínez Beneito MP; Marco Algarra J
Acta Otorrinolaringol Esp; 2000; 51(5):387-95. PubMed ID: 11000679
[TBL] [Abstract][Full Text] [Related]
10. Objective evaluation of the effects of intravenous lidocaine on tinnitus.
Kalcioglu MT; Bayindir T; Erdem T; Ozturan O
Hear Res; 2005 Jan; 199(1-2):81-8. PubMed ID: 15574302
[TBL] [Abstract][Full Text] [Related]
11. Absence of contralateral suppression of transiently evoked otoacoustic emissions in fibromyalgia syndrome.
Gunduz B; Bayazit YA; Celenk F; Saridoğan C; Guclu AG; Orcan E; Meray J
J Laryngol Otol; 2008 Oct; 122(10):1047-51. PubMed ID: 18318918
[TBL] [Abstract][Full Text] [Related]
12. [Effect of sedation on otoacoustic emissions].
Delb W; Merl E; Andes C; Koch A
Laryngorhinootologie; 1994 Jun; 73(6):315-9. PubMed ID: 8060450
[TBL] [Abstract][Full Text] [Related]
13. [The evolution of threshold values of air conduction in the extended high frequency range (9-18 kHz) in patients suffering from the pulmonary tuberculosis treated with combination of SM, INH, RFM, and PZA].
Gierek T; Markowski J; Kieda-Szurkowska J; Paluch J; Bielecki I
Pneumonol Alergol Pol; 2002; 70(5-6):296-304. PubMed ID: 12518629
[TBL] [Abstract][Full Text] [Related]
14. Clinical application of transiently evoked otoacoustic emissions after glycerol administration for diagnosis of sensorineural hearing loss.
Inoue Y; Kanzaki J; O-Uchi T; Ogawa K; Ogata A; Yoshihara S; Satoh Y
Auris Nasus Larynx; 1997 Apr; 24(2):143-9. PubMed ID: 9134136
[TBL] [Abstract][Full Text] [Related]
15. Distortion-product otoacoustic emission: early detection in deferoxamine induced ototoxicity.
Delehaye E; Capobianco S; Bertetto IB; Meloni F
Auris Nasus Larynx; 2008 Jun; 35(2):198-202. PubMed ID: 17869044
[TBL] [Abstract][Full Text] [Related]
16. [Assessment of cochlear function with distortion products of otoacoustic emissions in acoustic neuroma].
Oeken J
HNO; 1996 Dec; 44(12):677-84. PubMed ID: 9081952
[TBL] [Abstract][Full Text] [Related]
17. A rare case of streptomycin-induced toxic epidermal necrolysis in a patient with tuberculosis: a therapeutic dilemma.
Hmouda H; Laouani-Kechrid C; Nejib Karoui M; Denguezli M; Nouira R; Ghannouchi G
Ann Pharmacother; 2005 Jan; 39(1):165-8. PubMed ID: 15546942
[TBL] [Abstract][Full Text] [Related]
18. Ototoxicity screening of patients treated with streptomycin using distortion product otoacoustic emissions.
Md Daud MK; Mohamadl H; Haron A; Rahman NA
B-ENT; 2014; 10(1):53-8. PubMed ID: 24765829
[TBL] [Abstract][Full Text] [Related]
19. [Spontaneous otoacoustic emissions and efferent control of cochlea].
Xu J; Liu C; Guo L; Lian N; Liu B
Zhonghua Er Bi Yan Hou Ke Za Zhi; 2001 Dec; 36(6):436-40. PubMed ID: 12761959
[TBL] [Abstract][Full Text] [Related]
20. Newborn hearing screening by transient evoked otoacoustic emissions: analysis of response as a function of risk factors.
De Capua B; De Felice C; Costantini D; Bagnoli F; Passali D
Acta Otorhinolaryngol Ital; 2003 Feb; 23(1):16-20. PubMed ID: 12812130
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
